The size of the Pain Management Devices Market in the Asia Pacific was valued at USD 0.55 billion in 2021 and is expected to grow at a CAGR of 8.4%, to reach USD 0.83 billion by 2026 during the forecast period.
Pain is caused due to the unpleasant sensory stimulation caused due to damage to the tissues by any means. It is majorly caused by injuries and diseases such as arthritis, ulcers, cancer, and multiple sclerosis. Acute pain is caused for a concise period of time, whereas chronic pain is persistent for extended time periods.
Several drugs and devices are available in the market to assist in pain management. These devices work by blocking the nerve stimulators by transmitting the unpleasant sensory experience to the brain. Neurostimulation devices, ablation devices, and analgesic infusion pumps are some of the pain management devices. Neurostimulators block pain by supplying certain frequencies of current to prevent the passage of signals.
An increase in demand for alternatives for pain management drugs that cause many side effects, a large number of patients with chronic diseases, especially in the geriatric population, and technological advancements to develop better pain management devices are expected to drive the market. In addition, an increase in cancer patients and an increase in neuropathic diseases are also boosting the pain management devices market in the APAC region.
However, side effects of using these devices, such as hypersensitivity and redness of the skin and high manufacturing costs, restraining the APAC pain management devices market.
This research report on the APAC pain management devices market has been segmented and sub-segmented into the following categories:
By Device Type:
By Application:
By Mode of Purchase:
By Country:
Asia-Pacific has become a desirable location for companies that manufacture pain treatment equipment. Many factors can be attributed to high growth opportunities in that regional segment, including increased incidence of chronic diseases, improved health infrastructure in the region, the growing middle-class population and disposable revenue, and increased awareness of pain management devices safety and effectiveness. A sIn addition, a significant rise is seen in the elderly population in developing countries, like India, China, and Australia. Therefore, the growth of the APAC pain control devices market is projected to be boosted by the increasing elderly population and the development of pain control devices by local industry participants.
Japan and India are expected to drive the market in this region due to the increasing awareness about pain management devices and the rising geriatric population in these regions. In 2012, 30 million persons over 65 years old in Japan, and 39 million were expected to be present in 2030. The elderly population of Japan is steadily rising. In 2019, 25 percent of the population of Japan was above 65 and was anticipated to increase to 60.0% in 2060, according to the World Economic Forum. As population aging increases, there may be a rise in Japan's need for pain management systems throughout the predicted period.
The Indian pain management devices market is projected to account for a promising share in the APAC regional market during the forecast period. The market is driven by supportive government policies, increasing investments, and improving healthcare sectors—moreover, the pain management gadgets developed by firms in India. DJO Global, for instance, announced intentions to commercialize 10 pain management devices in India in September 2013. The business plans to commence operations in India, starting with 40 sites around the nation.
KEY MARKET PLAYERS:
A few notable players in the APAC pain management devices market profiled in the report are St. Jude Medical, Inc., Boston Scientific Corporation, Medtronic plc, Baxter International, Stryker Corporation, Pfizer, Codman and Shurtleff, B Braun Melsungen AG, and DJO Global LLC.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Device Type
5.1.1 Introduction
5.1.2 Neurostimulation Devices
5.1.2.1 Transcutaneous Electrical Nerve Stimulation (TENS) Devices
5.1.2.2 Spinal Cord Stimulation (SCS) Devices
5.1.3 Ablation Devices
5.1.3.1 RF Ablation Devices
5.1.3.2 Cryoablation Devices
5.1.4 Analgesic Infusion Pumps
5.1.4.1 Intrathecal Infusion Pumps
5.1.4.2 External Infusion Pumps
5.1.5 Y-o-Y Growth Analysis, By Device Type
5.1.6 Market Attractiveness Analysis, By Device Type
5.1.7 Market Share Analysis, By Device Type
5.2 Application
5.2.1 Introduction
5.2.2 Neuropathic Pain
5.2.3 Musculoskeletal Pain
5.2.4 Facial Pain and Migraine
5.2.5 Cancer Pain
5.2.6 Y-o-Y Growth Analysis, By Application
5.2.7 Market Attractiveness Analysis, By Application
5.2.8 Market Share Analysis, By Application
5.3 Mode of Purchase
5.3.1 Introduction
5.3.2 Over-the-Counter based
5.3.3 Prescription Based
5.3.4 Y-o-Y Growth Analysis, By Mode of Purchase
5.3.5 Market Attractiveness Analysis, By Mode of Purchase
5.3.6 Market Share Analysis, By Mode of Purchase
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Device Type
6.1.3.3 By Application
6.1.3.4 By Mode of Purchase
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Device Type
6.1.4.3 By Application
6.1.4.4 By Mode of Purchase
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Device Type
6.1.5.3 By Application
6.1.5.4 By Mode of Purchase
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 St. Jude Medical, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Boston Scientific Corporation
8.3 Medtronic plc
8.4 Baxter international
8.5 Stryker corporation
8.6 Pfizer
8.7 Codman and Shurtleff
8.8 B Braun Melsungen AG
8.9 DJO Global LLC.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
